Tommy G.  Thompson net worth and biography

Tommy Thompson Biography and Net Worth

Director of TherapeuticsMD
Tommy G. Thompson has served as the Chairman of the Board of Directors of our company since May 2012. Mr. Thompson currently serves as the Chief Executive officer of Thompson Holdings, a consulting firm. As the Governor of Wisconsin from January 1987 to February 2001, Secretary Thompson was perhaps best known for his efforts to revitalize the Wisconsin economy, for his national leadership on welfare reform, and for his work toward expanding health care access across all segments of society. As the former Secretary of the U.S. Department of Health & Human Services, or HHS, from February 2001 to January 2005, Secretary Thompson served as the nation’s leading advocate for the health and welfare of all Americans. Secretary Thompson was a partner in the law firm of Akin Gump Strauss Hauer & Feld LLP, or Akin Gump, from March 2005 to January 2012, when he resigned to run for the United States Senate. Secretary Thompson served as an Independent Chairman of the Deloitte Center for Health Solutions, a health care consulting company, from March 2005 to May 2009. At the Deloitte Center for Health Solutions and at Akin Gump, Secretary Thompson built on his efforts at HHS to work toward developing solutions to the health care challenges facing American families, businesses, communities, states, and the nation as a whole.

Secretary Thompson has also served as the President of Logistics Health, Inc., a provider of medical readiness and homeland security solutions, from February 2005 to January 2011. Secretary Thompson has served as a Senior Fellow for the Bipartisan Policy Center, a non profit organization focused on bipartisan advocacy and policymaking, since July 2013. Secretary Thompson also serves as a member of the board of directors for the following public companies: C. R. Bard, Inc. [NYSE: BCR], Centene Corporation [NYSE: CNC], United Therapeutics Corporation [NASDAQ: UTHR], Physicians Realty Trust [NYSE: DOC], and Cytori Therapeutics, Inc. [NASDAQ: CYTX]. Secretary Thompson is not standing for reelection to the board of Cytori Therapeutics. Secretary Thompson also served as a member of the boards of directors of CareView Communications, Inc. [OTCQB: CRVW] from July 2005 to January 2014, Cancer Genetics, Inc. [NASDAQ: CGIX] from 2008 to January 2014, Pure Bioscience, Inc. [NASDAQ: PURE] from February 2006 to August 2009, SpectraScience, Inc. [OTCBB: SCIE] from September 2007 to December 2009, AGA Medical Holdings, Inc. [NASDAQ: AGAM] from August 2005 to November 2010, and CNS Response, Inc. [OTCBB: CNSO.OB] from August 2009 to March 2010. We believe Secretary Thompson’s experience in public service, particularly his services and knowledge related to the health care industry as a whole, makes him well suited to serve on our Board of Directors. Secretary Thompson received both his B.S. and J.D. from the University of Wisconsin-Madison.

What is Tommy G. Thompson's net worth?

The estimated net worth of Tommy G. Thompson is at least $22,490.80 as of December 13th, 2022. Mr. Thompson owns 19,060 shares of TherapeuticsMD stock worth more than $22,491 as of December 17th. This net worth evaluation does not reflect any other assets that Mr. Thompson may own. Learn More about Tommy G. Thompson's net worth.

How do I contact Tommy G. Thompson?

The corporate mailing address for Mr. Thompson and other TherapeuticsMD executives is 951 Yamato Road Suite 220, BOCA RATON FL, 33431. TherapeuticsMD can also be reached via phone at (561) 961-1900 and via email at [email protected]. Learn More on Tommy G. Thompson's contact information.

Has Tommy G. Thompson been buying or selling shares of TherapeuticsMD?

Tommy G. Thompson has not been actively trading shares of TherapeuticsMD over the course of the past ninety days. Learn More on Tommy G. Thompson's trading history.

Who are TherapeuticsMD's active insiders?

TherapeuticsMD's insider roster includes Paul Bisaro (Director), Edward Borkowski (EVP), Cooper Collins (Director), James D'Arecca (CFO), Michael Donegan (CAO), Robert Finizio (CEO), Tommy Thompson (Director), and Marlan Walker (General Counsel). Learn More on TherapeuticsMD's active insiders.

Are insiders buying or selling shares of TherapeuticsMD?

In the last twelve months, TherapeuticsMD insiders bought shares 1 times. They purchased a total of 1,200 shares worth more than $2,040.00. The most recent insider tranaction occured on August, 21st when Director Cooper C Collins bought 1,200 shares worth more than $2,040.00. Insiders at TherapeuticsMD own 2.3% of the company. Learn More about insider trades at TherapeuticsMD.

Information on this page was last updated on 8/21/2024.

Tommy G. Thompson Insider Trading History at TherapeuticsMD

See Full Table

Tommy G. Thompson Buying and Selling Activity at TherapeuticsMD

This chart shows Tommy G. Thompson's buying and selling at TherapeuticsMD by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

TherapeuticsMD Company Overview

TherapeuticsMD logo
TherapeuticsMD, Inc. operates as a pharmaceutical royalty company in the United States. It has a license agreement with Mayne Pharma to commercialize the IMVEXXY, BIJUVA, and ANNOVERA prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brand names. The company sells its prescription pharmaceutical products and prenatal vitamin products through wholesale distributors and retail pharmacy distributors. TherapeuticsMD, Inc. was founded in 2008 and is headquartered in Boca Raton, Florida.
Read More

Today's Range

Now: $1.17
Low: $1.17
High: $1.21

50 Day Range

MA: $1.45
Low: $1.18
High: $1.62

2 Week Range

Now: $1.17
Low: $1.15
High: $2.75

Volume

10,244 shs

Average Volume

17,722 shs

Market Capitalization

$13.53 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.12